Healthcare

CONTACT US

Investor relations
Chris Davison
Head of Investor Relations
+44 20 7632 1000
investor.relations@permira.com
Human resources
Caroline Carr
Chief Human Resources Officer
+44 20 7632 1000
human.resources@permira.com
Communications
Noémie de Andia
Head of Communications
+44 20 7632 1000
media@permira.com
Marketing
Denise Gallagher
Marketing Manager
+44 20 7632 1000
marketing@permira.com
Permira Holdings Limited
Alistair Boyle
Guernsey
+44 1481 743200
Permira Debt Managers
James Greenwood
CEO
+44 2076321000

OUR OFFICES

Current investment

LSNE

LSNE is a leading contract development and manufacturing organisation specialising in sterile lyophilization and fill & finish of drugs and devices, serving a range of pharmaceutical, biotech and medical device customers. Find out how we are supporting their plans to increase its manufacturing footprint and expand its product offering…

2017Acquisition year
USCountry
20 yearsQuality regulatory history
3FDA approved facilities

Why we backed them

  • To back a leader in an attractive niche with key competitive advantages
  • To support a strong management team in a rapidly growing market which is predicted to grow 7-9% p.a.
  • To benefit from a market that has high barriers to entry given requirements of technical expertise, regulatory track record and capital investment

 

The investment strategy

  • To vertically integrate into the attractive active pharmaceutical ingredients (“API”) category
  • To broaden the manufacturing footprint across geographies
  • To expand capacity to enable further commercial-level contracts and extend capabilities to better serve better serve both US and European commercial customers

www.lyophilization.com